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Abstract
Background: While exposure to ambient air contaminants is clearly associated with adverse health outcomes,
disentangling mechanisms of pollutant interactions remains a challenge.
Objectives: We aimed at characterizing free radical pathways and the endothelinergic system in rats after inhalation of
urban particulate matter, ozone, and a combination of particles plus ozone to gain insight into pollutant-specific
toxicity mechanisms and any effect modification due to air pollutant mixtures.
Methods: Fischer 344 rats were exposed for 4 h to a 3 × 3 concentration matrix of ozone (0, 0.4, 0.8 ppm) and EHC-93
particles (0, 5, 50 mg/m3). Bronchoalveolar lavage fluid (BALF), BAL cells, blood and plasma were analysed for
biomarkers of effects immediately and 24 h post-exposure.
Results: Inhalation of ozone increased (p < 0.05) lipid oxidation products in BAL cells immediately post-exposure, and
increased (p < 0.05) total protein, neutrophils and mature macrophages in the BALF 24 h post-exposure. Ozone increased
(p < 0.05) the formation of reactive oxygen species (ROS), assessed by m-, p-, o-tyrosines in BALF (Ozone main
effects, p < 0.05), while formation of reactive nitrogen species (RNS), indicated by 3-nitrotyrosine, correlated
with dose of urban particles (EHC-93 main effects or EHC-93 × Ozone interactions, p < 0.05). Carboxyhemoglobin levels in
blood exhibited particle exposure-related increase (p < 0.05) 24 h post recovery. Plasma 3-nitrotyrosine and
o-tyrosine were increased (p < 0.05) after inhalation of particles; the effect on 3-nitrotyrosine was abrogated
after exposure to ozone plus particles (EHC-93 × Ozone, p < 0.05). Big endothelin-1 (BET-1) and ET-1 were
increased in plasma after inhalation of particles or ozone alone, but the effects appeared to be attenuated
by co-exposure to contaminants (EHC-93 × Ozone, p < 0.05). Plasma ET levels were positively correlated (p < 0.05) with
BALF m- and o-tyrosine levels.
Conclusions: Pollutant-specific changes can be amplified or abrogated following multi-pollutant exposures. Oxidative
and nitrative stress in the lung compartment may contribute to secondary extra-pulmonary ROS/RNS formation.
Nitrative stress and endothelinergic imbalance emerge as potential key pathways of air pollutant health effects, notably
of ambient particulate matter.
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Background
Episodic increases in ambient air contaminant levels have
clearly been associated with increased respiratory and car-
diovascular morbidity and mortality [1–3]. Traffic-related
air pollution affects the autonomic control of the heart
and decreases heart rate variability, an indicator of cardiac
risk [4]. Air pollution has now been implicated in diverse
health impacts such as stroke, Alzheimer’s pathology,
mood disorders, gastrointestinal disorders, low infant birth
weight and cancer [5–10]. Notwithstanding the strong evi-
dence for adverse health impacts of ambient air pollutants,
there remain important knowledge gaps in our under-
standing of the toxicity mechanisms and the biological
plausibility of adverse health outcomes [11]. Notably, dir-
ect experimental investigations of contaminant interac-
tions are scarce, and disentanglement of the effects of
contaminants inhaled as mixtures in population studies
must rely on statistical filters. Understanding of the toxico-
dynamics of ambient air pollutants and their interactions
should allow the development of risk estimate models
grounded on direct evidence.
Air pollution is a complex matrix of gases and particu-
late matter with highly variable physico-chemical charac-
teristics depending on generation mode and sources e.g.
point industrial sources, automotive combustion, natural
processes such as wild fires and volcanic eruptions, atmos-
pheric conditions. Reactive gases such as ozone, oxides of
nitrogen, carbon monoxide, sulphur dioxide and particu-
late matter of varying size modes (e.g. PM10, PM2.5, ul-
trafine particles) constitute the air pollutant mixture. Air
particles are known sinks for various organics and a num-
ber of inorganic chemicals including physiologically active
transition metals [12]. Thus investigations of air pollution
exposure-induced toxicity mechanisms have become more
challenging due to the complexity of air pollutant mix-
tures [13].
Free radical species are formed in biological systems dur-
ing cellular respiration at normal physiological levels and
they contribute to cellular signal transduction pathways
and host defence mechanisms [14]. However, exposure to
external stimuli such as air pollutants can result in an ex-
cessive generation of free radical intermediates (reactive
oxygen species ROS and reactive nitrogen species RNS)
and tilt the oxidant/antioxidant balance in the biological
system leading to oxidative stress. Reactive gases such as
ozone have been reported to function as pulmonary irri-
tants since they can trigger free radical formation that can
lead to lung inflammation [15–17]. Squadrito et al., [18] re-
ported that air particles, namely PM 2.5 contained abun-
dant persistent semiquinone radicals. These radicals can
contribute to redox cycling reactions in vivo. It is therefore
feasible that exposure to air pollutants can lead to the for-
mation of reactive free radicals which can trigger or modu-
late onset of existing pathological conditions.
We have previously shown that exposure of rats to ozone
by inhalation can cause the generation of hydroxyl radicals
and reactive oxygen species [16, 19, 20]. We have also ob-
served the formation of reactive intermediate-derived me-
tabolites in TNFα-positive transgenic mice exposed by
inhalation to a mixture of ozone and air particles for
90 days [21]. Ambient particulate matter and combustion-
generated particles including diesel exhaust particles have
been shown to contribute to the formation of reactive oxy-
gen species [22, 23]. We have also shown previously that
air particle exposures led to increased blood pressure in an-
imals along with increased levels of circulating endothelin
ET-1, a potent vasoconstrictor peptide [24]. Endothelin-1 is
a known prognostic factor for cardiovascular diseases.
The objectives of this study were to first, identify system-
atically if there were differences in in vivo oxidative stress
mechanisms due to the type of air pollutant exposure such
as ozone, particulate matter or to mixtures. Secondly, we
intended to assess the effect of these air pollutant expo-
sures on the integrity of the vascular endothelium. Thirdly,
our goal was to investigate any association between air
pollutant-induced oxidative stress and vasoregulatory
mechanisms. Finally, our aim was to analyse for inter-
pollutant interactions and recovery time-related effects.
The main goal was to investigate if oxidative stress and
vascular dysfunction-related pathways can permit dis-
entanglement of effects caused by individual pollutants
within the air pollutant mixtures. In order to achieve these
objectives, we exposed male Fisher 344 rats either to
ozone, ambient air particles or various mixtures of these
pollutants and measured various relevant biological end-
points at immediately and 24 h post-exposure.
Results
Lung injury markers
Total BAL cells were decreased by 20 % immediately post-
exposure to 0.8 ppm O3 but increased slightly 24 h post-
exposure (Fig. 1a; 3-way ANOVA, Ozone x Recovery,
p < 0.001), a pattern of change attributed to the total
macrophage population (Fig. 1b; 3-way ANOVA, Ozone ×
Recovery, p = 0.001; 2-way ANOVA, Ozone × EHC-93,
p = 0.024). Note: Statistical analysis was conducted on
rank transformed data for macrophages, neutrophils and
mature macrophages to meet the assumptions for normal-
ity and equal variance. Neutrophils were increased 12-fold
(Fig. 1c; 3-way ANOVA, Ozone × Recovery, p = 0.011),
while mature macrophages were increased by about 2-fold
24 h post-exposure to 0.8 ppm O3, without any effects of
particle deposition (Fig. 1d; 3-way ANOVA, Ozone ×
Recovery, p = 0.029). Changes of lipid oxidation products
formaldehyde (Fig. 2a; 2-way ANOVA, Ozone, p = 0.007),
propanal (Fig. 2b; Ozone, p = 0.010) and 4-hydroxynonenal
(Fig. 2c; Ozone, p = 0.008) in total BAL cells were related to
inhalation of O3 and not particles. Both O3 (3-way
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ANOVA, Ozone x Recovery, p < 0.001; 2-way ANOVA,
Ozone main effect, p < 0.001) and particles (three-way
ANOVA, EHC-93 main effect, p = 0.048) increased the pH
value of the BALF supernatants, immediately after and
24 h after exposure, with apparent simple additive effects
of the pollutants (Fig. 3a). Exposure to O3 elevated total
BALF protein 1.5-fold immediately, and 3.5-fold 24 h after
exposure, without any main effects or interaction of parti-
cles (Fig. 3b; 3-way ANOVA, Ozone x Recovery, p < 0.001;
2-way ANOVA, Ozone, p < 0.001).
BALF oxidative stress markers
Exposure to O3 enhanced (p < 0.05) m- o- and p-tyrosine
levels in BALF (Fig. 4a–c; 2-way ANOVA, Ozone main ef-
fect, p < 0.001). Ozone and particles could independently
increase 3-nitrotyrosine in BALF, but also with interaction
(Fig. 4d; 3-way ANOVA, Ozone x EHC-93, p = 0.011, Re-
covery main effect, p = 0.013; 2-way ANOVA, EHC-93
main effect, p < 0.001). The ratio of 3-nitrotyrosine to L-
DOPA, which provides a ratio of the relative activity of ni-
tration pathways over that of hydroxylation pathways, was
increased with exposure to EHC-93 only, both immediately
and 24 h post recovery period, with apparent competition
of hydroxylation over nitration at 0.4 ppm O3 (Fig. 4e;
3-way ANOVA, EHC-93 main effect, p < 0.001; 2-way
ANOVA, EHC-93 ×Ozone, p = 0.032). Protein carbonyl
levels in BALF were not significantly altered by the pollut-
ants (Additional file 1).
Hemoglobin
Interestingly, inhalation of both pollutants altered the
levels of methemoglobin in a recovery-dependent man-
ner after exposure (Fig. 5a; 3-way ANOVA, Ozone ×
EHC-93, p = 0.024, EHC-93 × Recovery, p = 0.035; 2-way
ANOVA, Ozone, p = 0.009). However, inhalation of par-
ticles elevated carboxyhemoglobin even after 24 h post
recovery (Fig. 5b; 3-way ANOVA, EHC-93 main effect,
p < 0.001, Recovery main effect, p = 0.044). Furthermore,
the levels of oxyhemoglobin and sulfhemoglobin were
not affected significantly by these pollutant exposures.
Plasma oxidative stress markers
Changes of plasma m-tyrosine levels after exposure to air
contaminants did not reach statistical significance (Fig. 6a),
while o-tyrosine (Fig. 6b; 3-way ANOVA, Ozone × EHC-
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Fig. 1 Bronchoalveolar lavage cytology. Results expressed as mean fold-effect ± SEM. a. Total cell count. 3-way ANOVA, Ozone x Recovery, p < 0.001.
Tukey, *0 vs 0.8 ppm O3 within 24 h recovery, and 0 h vs 24 h recovery within 0 and 0.8 ppm O3, p < 0.05. 2-way ANOVA, Ozone, p < 0.001. Tukey,
#0
and 0.4 vs 0.8 ppm O3, p < 0.05. b. Total macrophages count. 3-way ANOVA, Ozone × Recovery, p < 0.001. *0 vs 0.8 ppm O3 within 24 h. 2-way ANOVA,
Ozone × EHC-93, p = 0.024. Tukey summarized by lines (e.g. 0 vs 5 mg/m3 EHC-93 within 0 ppm O3), p < 0.05. c. Total neutrophils count. 3-way ANOVA,
Ozone × Recovery, p = 0.011 and Ozone × EHC-93, p = 0.030. Tukey, *0 vs 0.8 ppm O3 within 24 and 0 h vs 24 h within 0.8 ppm O3. d. Total mature
macrophages. 3-way ANOVA, Ozone × Recovery, p = 0.029. Tukey, 0 vs 0.8 ppm O3 within 24 h. For detailed statistics, refer to Additional files 4 & 6.
(Sample size, n = 8/air pollutant exposure group; n = 17/air control group)
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and p-tyrosine (Fig. 6c; 3-way ANOVA, Ozone × Recovery,
p < 0.001, EHC-93 main effect, p < 0.001; 2-way ANOVA,
EHC-93 main effect, p = 0.010) were affected by both pol-
lutants. Inhalation of the particles resulted in a nitra-
tive stress with elevation of 3-nitrotyrosine, a response
that was partly abrogated by high concentration of O3
(Fig. 6d; 3-way ANOVA, Ozone × EHC-93, p = 0.026; 2-
way ANOVA, EHC-93 main effect, p = 0.035). Ratio of ni-
tration to hydroxylation, indicated by 3-nitrotyrosine over
L-DOPA presented a similar pattern, with elevation by
EHC-93 and abrogation by O3 (Fig. 6e; 3-way ANOVA,
p = 0.044; 2-way ANOVA, Ozone main effect, p = 0.029.





















































































Fig. 2 Lipid oxidation products in the BAL cells immediately post-
exposure to air pollutants. Mean fold-effect ± SEM. a. Formaldehyde.
2-way ANOVA, Ozone, p = 0.007. Tukey, *0 vs 0.8 ppm O3, p < 0.05.
b. Propanal. 2-way ANOVA, Ozone, p= 0.010. Tukey, *0 vs 0.8 ppm O3,
p< 0.05. c. 4-Hydroxynonenal. 2-way ANOVA, Ozone, p= 0.008. Tukey, *0
vs 0.8 ppm O3, p < 0.05. For detailed statistics, refer to Additional file 6.
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Fig. 3 BALF injury markers. a. pH of BALF. Mean ± SEM. 3-way ANOVA,
EHC-93, p= 0.048 and Ozone × Recovery, p < 0.001. Tukey, *0 vs 50 mg/
m3 EHC-93, †0 h vs 24 h within 0.8 ppm O3,
‡0 h vs 24 h within 0 ppm
O3, p< 0.05. 2-way ANOVA, Ozone, p < 0.001. Tukey,
#0 and 0.4 vs
0.8 ppm O3, p < 0.05. b. BALF protein. Mean fold-effect ± SEM. 3-way
ANOVA, Ozone x Recovery, p< 0.001. Tukey, *0 h vs 24 h within 0.8 ppm
O3,
#0 h vs 24 h within 0 ppm O3, p < 0.05. 2-way ANOVA, Ozone,
p < 0.001. Tukey, †0 and 0.4 vs 0.8 ppm O3, p < 0.05. For detailed
statistics, refer to Additional files 4 & 6. (Sample size, n = 8/air
pollutant exposure group; n = 17/air control group)
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Fig. 4 (See legend on next page.)
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plasma was similar to that of 3-nitrotyrosine, but changes
did not reach significance (Additional file 2).
Endothelial dysfunction markers
Analysis of circulating endothelin isoform levels revealed
an increase of BET-1 (Fig. 7a) and ET-1 (Fig. 7b) after
exposures to either EHC-93 or O3, with a negative
interaction when inhaled together (3-way and 2-way
ANOVA, Ozone × EHC-93, p < 0.001). There were no
significant changes of the ET-2 isoform in plasma (Fig. 7c),
while ET-3 was affected by O3 (Fig. 7d; 3-way ANOVA,
Ozone × EHC-93, p = 0.021). While elevation of BET-1 re-
flects mainly increased de novo synthesis, the ratio ET-1/
BET-1 as an index of the rate of ECE-1 conversion of BET-
1 to ET-1 was elevated after exposure to the pollutants
(Fig. 7e; 3-way ANOVA, EHC-93 × Recovery, p = 0.041,
Ozone × EHC-93, p < 0.001; 2-way ANOVA, Ozone ×
EHC-93, p = 0.006). The ratio ET-1/ET-3 as an index of
ET[A] receptor mediated vasoconstriction and ET[B] re-
ceptor mediated vasodilation followed a pattern very
similar to that of ET-1 (Fig. 7f; 3-way and 2-way ANOVA,
p ≤ 0.001). Changes of plasma nitrite levels were not statis-
tically significant (Additional file 3). The levels of m-
tyrosine in BALF were positively correlated with circulat-
ing BET-1 (Spearman rank order, r = 0.330, p = 0.033) and
ET-1 (Spearman, r = 0.309, p = 0.047) levels. Plasma o-
tyrosine levels were positively correlated with circulating
ET-1 (Spearman, r = 0.211, p = 0.015). Backward stepwise
regression analyses indicated that BALF m-tyrosine was a
predictor of plasma BET-1 (p = 0.028), while a linear com-
bination of BALF m-tyrosine (p = 0.015) and plasma BET-
1 (p < 0.001) were predictors of circulating levels of ET-1.
Discussion
In this study, we investigated the impact of inhaled ozone,
airborne particles and the mixtures on nitrative stress, oxi-
dative stress and circulating endothelin levels in experi-
mental animals. The urban air particle EHC-93 has been
used widely as a model particle in air pollutant toxicity in-
vestigations [8, 21, 24–26]. As discussed before, while the
absolute concentration of the total suspended particulate
matter is high relative to PM2.5 levels in North America,
the alveolar deposited dose of fine particulate mass is
within an order of magnitude of realistic human exposure
scenario.[24] The elevation of the total number of neutro-
phils (Fig. 1c) and protein (Fig. 3b) levels in BAL con-
firmed lung injury attributable mainly to O3 [27, 28].
Analysis of BAL cells for oxidized lipids such as formal-
dehyde, propanal and 4-hydroxynonenal revealed increased
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Fig. 5 Hemoglobin variants in whole blood. Mean absorbance ± SEM.
a. Methemoglobin. 3-way ANOVA, Ozone × EHC-93, p = 0.024 and
EHC-93 × Recovery, p = 0.035. Tukey, *0 vs 0.8 ppm O3 within 0 mg/
m3 EHC-93, †0 h vs 24 h Recovery within 50 mg/m3 EHC-93, p < 0.05. 2-
way ANOVA, Ozone, p = 0.009. Tukey, #0.4 vs 0.8 ppm O3, p < 0.05.
b. Carboxyhemoglobin. 3-way ANOVA, EHC-93, p< 0.001 and Recovery,
p= 0.044. Tukey, *0 vs 50 mg/m3 EHC-93, †0 h vs 24 h Recovery, p< 0.05.
For detailed statistics, refer to Additional files 5 & 7. (Sample size, n= 4/air
pollutant exposure group; n= 6/air control group)
(See figure on previous page.)
Fig. 4 BALF markers of ROS and RNS formation. Mean fold-effect ± SEM. a. m-Tyrosine. 3-way ANOVA, Ozone × Recovery, p< 0.001. Tukey, *0 vs 0.8 ppm
O3 within 24 h, p< 0.05. 2-way ANOVA, Ozone, p< 0.001. Tukey,
#0 and 0.4 vs 0.8 ppm O3, p < 0.05. b. o-Tyrosine. 3-way ANOVA, Recovery, p= 0.047.
Tukey, 0 h vs 24 h, p< 0.05. 2-way ANOVA, Ozone, p< 0.001. Tukey, *0 and 0.8 vs 0.4 ppm O3, p < 0.05. c. p-Tyrosine. 3-way ANOVA, Ozone, p< 0.001.
Tukey, *0 vs 0.8 ppm O3, p < 0.05. 2-way ANOVA, Ozone, p < 0.001. Tukey, 0 vs 0.4 and 0.8 ppm O3, p < 0.05. d. 3-Nitrotyrosine. 3-way
ANOVA, Recovery, p = 0.013 and Ozone × EHC-93, p = 0.011. Tukey, 0 h vs 24 h, *0 vs 50 mg/m3 within 0 and 0.8 ppm O3,
#0 vs 0.8 ppm
O3 within 0 and 50 mg/m
3, p < 0.05. 2-way ANOVA, EHC-93, p < 0.001. Tukey, †0 and 5 vs 50 mg/m3, p < 0.05. e. 3-Nitrotyrosine/L-Dopa. 3-way
ANOVA, EHC-93, p < 0.001. Tukey, *0 vs 50 mg/m3 EHC-93, p < 0.05. 2-way ANOVA, EHC-93 × Ozone, p = 0.032. Tukey, *0 and 5 vs 50 mg/m3 EHC-93
within 0 ppm O3 and 0 vs 50 mg/m
3 EHC-93 within 0.8 ppm O3, p < 0.05. For detailed statistics, refer to Additional files 4 & 6. (Sample
size, n = 8/air pollutant exposure group; n = 15/air control group)
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ozone (Fig. 2). This observation can be attributed to reac-
tion of ozone with unsaturated lipids in these cells, poten-
tially via an “ozonide” intermediate that cleaves to form
aldehydes and hydrogen peroxide (H2O2) [16, 29]. These
changes were not noticed with animals exposed to EHC-93
alone, even though air particles can contribute to redox
cycling-related lipid oxidation. This observation illustrates
an ozone exposure-specific biological change at the target
site (Fig. 2). The fact that ozone exposure led to lipid oxida-
tion product formation in BAL cells immediately after ex-
posure which was followed by increased BAL neutrophils
after 24 h post-exposure suggest that these lipid oxidation
products perhaps contributed to defence cell recruitment
mechanisms. This is in line with a previous report where
intervention with quercertin reduced lipid oxidation prod-
uct formation in alveolar macrophages and a concurrent
reduction in neutrophil infiltration [30]. Similarly, the ob-
servation of increased mature macrophages at 24 h post
recovery after ozone exposure could be linked to in-
creased lipid oxidation in BAL cells as well. This is sup-
ported by previous reports on increased lipid oxidation,
foam cell formation and presence of mature macrophages
in lungs especially after a lung infection or oxidant insult
that is typically associated with inflammatory diseases of
the lung [31, 32].
The observation of increased BAL Fluid (BALF) protein
levels in animals exposed to ozone as a constituent of the
pollutant matrix, after 24 h post recovery suggested com-
promised cellular membrane integrity (Fig. 3b). Increased
BAL neutrophils and BALF protein in the lung suggest in-
flammation or irritation of lungs when exposed to ozone
containing atmospheres as opposed to air particles, when
such frank effects are not observed.
We also noticed differences in the kinetics of formation
of m-, o- and p-tyrosine isomers immediately and 24 h
post-exposure to pollutants, in this study. In vivo formation
of reactive oxygen species (ROS) notably OH•, has been
shown to react with phenylalanine to form these m-, o-
and p- tyrosines [33]. p-Tyrosine can also be formed enzy-
matically. Levels of m-tyrosine in BALF exhibited a clear
dose-related increase in ozone exposed animals, immedi-
ately after exposure (Fig. 4), whereas, p- and o-tyrosine iso-
mers exhibited non-monotonic changes with increasing
ozone dose. Particle exposures appeared to impact on
BALF o-tyrosine levels. Ambient air particles host a variety
of metal species including transition metals which can
favour o-tyrosine formation compared to the other tyrosine
isomers by the formation of a relatively stable metal com-
plex intermediate involving the “R (−CH2CHNH2COOH)”
moiety in phenylalanine and the “ortho” position adjacent
to it. The corresponding intermediate metal complexes as-
sociated with the formation of m- or p- isomers may not
be energetically feasible. This notion is consistent with pre-
vious reports on formation of o-tyrosine and dityrosine as
a result of metal catalyzed oxidation [34]. When exposed to
air pollutant mixtures, m-, o- and p-tyrosine levels were
modified by the constituents (Fig. 4). Ozone and EHC-93
particles apparently modulated the effects caused by the
other. This is revealed by BALF p-tyrosine levels that ex-
hibited additive effect, while o-tyrosine levels showed a
suppressive effect, especially at 24 h post-exposure to pollu-
tant mixtures.
3-Nitrotyrosine, a product of tyrosine nitration exhib-
ited a dose-related increase in BALF of EHC-93 exposed
animals, which was modulated by the level of ozone in
the mixtures (Fig. 4). Reaction of tyrosine with peroxyni-
trite, a reactive nitrogen intermediate can lead to the for-
mation of 3-nitrotyrosine. Peroxynitrite can be formed
as a result of the reaction of superoxide (O2
−•) with NO•
or due to a reaction of OH• with NO2 or H2O2 with
NO•, at diffusion limited rates [35]. Reactive oxygen spe-
cies can be generated in vivo as a result of ozone or
EHC-93 exposures [24, 36]. Meanwhile, EHC-93 parti-
cles perhaps can trigger host-defense mechanisms up-
regulating inducible nitric oxide synthase iNOS and thus
NO• production. Although these particles do not cause
pulmonary inflammation, interestingly there was an in-
creasing trend in total BAL cells immediately post ex-
posure when the animals were exposed to particles alone
which may have led to increase in iNOS [37] and thus NO•
production in lung. Squadrito et al. [18] have shown that
when engulfed by BAL cells, particles enhanced NO• pro-
duction that results in peroxynitrite formation. Further-
more, at physiological conditions, pH has been shown to
influence tyrosine nitration [38]. Interestingly, pH values of
BALF (Fig. 3) from animals exposed to EHC-93 were rela-
tively low compared to those of ozone exposed animals.
Under such conditions, particle exposures presumably lead
(See figure on previous page.)
Fig. 6 Plasma markers of ROS and RNS formation. Mean fold-effect ± SEM. a. m-Tyrosine, not significant. b. o-Tyrosine. 3-way ANOVA, Ozone × EHC-93,
p = 0.025. Tukey, *0 vs 0.8 ppm O3 within 0 mg/m
3 EHC-93, #0 vs 50 mg/m3 EHC-93 within 0 ppm O3, p < 0.05. 2-way ANOVA, Ozone × EHC-93, p = 040.
Tukey, †0 vs 0.4 ppm O3 within 50 mg/m
3 EHC-93, p < 0.05. c. p-Tyrosine. 3-way ANOVA, EHC-93, p < 0.001 and Ozone × Recovery, p < 0.001. Tukey, *0 vs
50 mg/m3 EHC-93, #0 vs 0.8 ppm O3 within 24 h,
†0 vs 0.8 ppm O3 within 0 h recovery, p < 0.05. 2-way ANOVA, EHC-93, p = 0.010. Tukey, *0 vs 50 mg/
m3 EHC-93, p < 0.05. d. 3-Nitrotyrosine. 3-way ANOVA, Ozone × EHC-93, p = 0.026. Tukey, *0 vs 0.8 ppm O3 within 0 mg/m
3 EHC-93, #0 vs
50 mg/m3 EHC-93 with 0 ppm O3, p < 0.05. 2-way ANOVA, EHC-93, p = 0.035. Tukey,
†0 vs 50 mg/m3 EHC-93, p < 0.05. e. 3-Nitrotyrosine/L-Dopa. 3-way
ANOVA, EHC-93, p = 0.044. Tukey, *0 vs 50 mg/m3 EHC-93, p < 0.05. 2-way ANOVA, Ozone, p = 0.029. Tukey, #0.4 vs 0.8 ppm O3, p < 0.05. For detailed
statistics, refer to Additional files 5 & 7. (Sample size, n = 7–8/air pollutant exposure group; n = 14/air control group)
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Fig. 7 Plasma endothelin isoforms. Mean fold-effect ± SEM. a. BET-1. 3-way ANOVA and 2-way ANOVA, Ozone × EHC-93, p < 0.001. Tukey multiple
comparisons, lines, p < 0.05. b. ET-1. 3-way ANOVA and 2-way ANOVA, Ozone × EHC-93, p < 0.001. Tukey multiple comparisons, lines, p < 0.05. c. ET-2,
not significant. d. ET-3. 3-way ANOVA, Ozone × EHC-93, p = 0.021. Tukey, *0 vs 0.8 ppm O3 within 0 mg/m
3 EHC-93. E. Ratio ET-1/BET-1. 3-way ANOVA,
Ozone × EHC-93, p < 0.001 and EHC-93 × Recovery, p = 0.041. Tukey, *0 vs 50 mg/m3 EHC-93 within 24 h recovery, #0 h vs 24 h within 50 mg/m3
EHC-93, †0 vs 0.8 ppm O3 within 0 mg/m3 EHC-93, &0 vs 50 mg/m3 EHC-93 within 0 ppm O3, p < 0.05. 2-way ANOVA, Ozone × EHC-93, p = 0.006. Tukey
comparisons, lines, p < 0.05. f. Ratio ET-1/ET-3. 3-way ANOVA, Ozone × EHC-93, p < 0.001. Tukey, *0 vs 0.8 ppm O3 within 50 mg/m
3 EHC-93, #0 vs
0.8 ppm O3 within 0 mg/m
3 EHC-93, †0 vs 50 mg/m3 within 0 and 0.8 ppm O3, p < 0.05. 2-way ANOVA, Ozone × EHC-93, p = 0.001. Tukey, lines,
p < 0.05. For detailed statistics, refer to Additional files 5 & 7. (Sample size, n = 7–8/air pollutant exposure group; n = 14/air control group)
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to the formation of “peroxynitrous acid” which can subse-
quently undergo heterolytic cleavage to yield “nitronium”
ion that nitrates p-tyrosine residues in proteins. It is known
that formation of “nitronium” ion from peroxynitrite is
favoured in the presence of protein bound or free metal
ions [39]. The profiles of 3-nitrotyrosine to L-dopa ratio
(Fig. 4) can serve as a measurement of the competition
between RNS and ROS-mediated reactions. L-dopa is a
hydroxylation product of p-tyrosine and can be formed
by reaction with OH•. Our data on 3-Nitrotyrosine to
L-dopa ratio values revealed that with EHC-93 expo-
sures, RNS-mediated reaction was favoured compared
to ROS-dependent reaction as opposed to exposure to
ozone alone in BALF. These observations also suggest
clear EHC-93 particle-exposure specific differences in
the lungs of exposed animals.
In this work, exposure to air pollutants affected the
blood levels of hemoglobin variants, especially carboxy-
hemoglobin (COHb) and methemoglobin (Fig. 5). These
changes were sustained even after 24 h post-exposure
only in particle exposed animals. These hemoglobin vari-
ants are also known to form for instance during CO,
and NO exposures [40–42] and have been associated
with negative impacts on health [43]. We have reported
previously an increase of heme oxygenase-1 gene expres-
sion in these same animals, notably in the lungs, heart
and liver after 24 h recovery following inhalation of
EHC-93 [37]. There are reports on particle exposure and
heme oxygenase-1 levels in circulation [44]. This implies
that deposition of ambient particles in the lungs can ini-
tiate a systemic response that activates endogenous CO
production. It appears that in our model, sufficient CO
was produced to shift COHb levels which can potentially
decrease oxygen delivery to tissues. This is a significant
observation that supports biological plausibility and adds
to the weight of evidence for adverse cardiovascular im-
pacts of respirable ambient particulate matter.
Although primary targets of inhaled pollutants are the
lung lining and resident alveolar macrophages and pri-
mary local changes are anticipated here, we hypothesised
that secondary effects probably can be seen in other
tissues, such as plasma due to the onset of free radical
cascades. Moreover, in the case of particle exposures,
secondary effects in extra-pulmonary sites can also be due
to translocation of particles to other sites. Our results
indicated that plasma profiles of ROS products m-, o-, p-
tyrosines were somewhat different from that of BALF pro-
files. Nevertheless, the profiles of 3-nitrotyrosine and the
3—nitrotyrosine to L-DOPA ratio in plasma exhibited
similarity to those in BALF. Furthermore, o-tyrosine levels
showed dose-related increases both at immediately post-
exposure to ozone alone as well as to EHC-93 alone, and
these changes were sustained even at 24 h post-exposure
(Fig. 6). However, when exposed to O3 plus EHC-93
mixture, o-tyrosine levels exhibited significant inter-
pollutant interactions (Ozone x EHC-93, p = 0.025). This
can be reflective of a secondary oxidative stress condition
set beyond what we noted at the target sites. The observa-
tion of relatively steeper slope for the plasma o-tyrosine
dose—response curve with EHC-93 exposure compared
to ozone suggests that in animals exposed to particles,
metal-catalyzed oxidation reactions could favour o-
tyrosine formation in plasma as well [34, 45, 46].
Even though inhalation of O3 led to some 3—nitro-
tyrosine formation in plasma, the effect was not dose-
dependent. In contrast, inhalation exposure to EHC-93 led
to a linear dose-related increase in plasma 3-nitrotyrosine
levels. When animals were exposed to the pollutant mix-
tures, inter-pollutant interactions were noticed in the
3-nitrotyrosine levels. Yet at 24 h post-exposure to
pollutant mixtures, this RNS marker appeared to be solely
affected by EHC-93 particle exposure. Interestingly, al-
though we did not see significant changes in the plasma
levels of 8-isoPGF2α, a lipid oxidation marker (Additional
file 2), it appeared to track the 3-nitrotyrosine levels in
circulation. It is to be noted here that “superoxide
anion” is implicated in the formation of both 8-
isoPGF2α and 3-nitrotyrosine. Similar observations have
been noted with diesel exposures [47].
Plasmatic levels of endothelin-1 (ET-1), a potent vaso-
constrictor peptide and its precursor big endothelin-1
(BET-1) were increased in animals immediately post-
exposure to O3 or EHC-93, but pollutant co-exposures led
to a negative interaction. Endothelins are a family of vaso-
active peptides (21 amino acids) consisting of three distinct
isoforms, endothelin-1 (ET-1), endothelin-2 (ET-2) and
endothelin-3 (ET-3) and are coded by different genes [48].
The mature endothelins (ET-1, −2 and −3) are produced
in vivo from cleavage of their corresponding big endothe-
lins (BET) by endothelin-converting enzymes [49, 50].
Endothelin-1, the most abundant isoform with diverse bio-
logical activity, has been implicated in several diseases,
particularly in the progression of cardiovascular disease
[51, 52]. At 24 h post-recovery, the effects due to individ-
ual pollutants were somewhat sustained for both BET-1
and its conversion product ET-1. This is consistent with
our previous findings on animals and humans exposed to
air pollutants [23, 27]. However, when exposed to the
pollutant mixture, at 24 h post exposure, both BET-1 and
ET-1 levels in circulation decreased compared to when ex-
posed to individual pollutants. This decrease in BET-1 and
ET-1 (ET1–21) levels after exposure to high dose pollutant
mixtures at both immediately and 24 h post-exposure can
be attributed to a heightened alternative MMP-2 directed
BET-1 cleavage, leading to the formation of ET1–32 as dis-
cussed in our previous report [43]. The decrease in ET-1
levels in plasma could also be due to increased clearance
via ET [B] receptor binding [53], at high dose exposure to
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pollutant mixtures. Although there were no significant
changes noted with the levels of circulating ET-2 isoform,
the ET-3 isoform tracked the profile changes of ET-1
through the different exposure conditions.
The plasma ET-1/BET-1 ratio values (Fig. 7e) can serve
as a measure of endothelin converting enzyme (ECE) ac-
tivity with air pollutant exposures. These results suggested
that air pollutants individually or as mixtures perhaps im-
pacted on ECE activity both immediately and at 24 h post-
exposure. The plasmatic ET-1/ET-3 ratio profile (Fig. 7f)
can function as a descriptor of balance between vasocon-
strictive and vasorelaxing mechanisms [54], and our data
suggest that at 24 h post-exposure to pollutant mixtures,
compensatory vasodilatory mechanisms may be triggered
to increase ET-1 clearance and/or decrease de novo syn-
thesis. Our observations of a positive correlation between
ET-1 and ET-3 in plasma, and that plasmatic ET-1 levels
were predicted by plasma BET-1 levels argue in favour of
co-regulation mechanisms [54]. Also, the plasma free ni-
trite analysis results (See Additional file 3) exhibited an in-
creasing trend with particle exposures, but non-monotonic
changes were seen with increasing ozone doses, immedi-
ately post-exposure (not significant), and systemic inflam-
mation with increased iNOS activity cannot be ruled out
[43]. However, at 24 h post-exposure, free nitrite levels in
circulation were relatively higher (not significant) in ani-
mals exposed to the pollutant mixture consistent with en-
hanced compensatory effect as mentioned before.
Oxidative stress has been implicated in vascular dysfunc-
tion [55, 56]. In our work, Correlation analysis results ex-
hibited significant (p < 0.05) positive association between
BALF m-tyrosine levels and plasmatic BET-1 (r = 0.330)
and ET-1 (r = 0.309) levels. Similarly, BALF o-tyrosine
levels were positively correlated with and plasmatic BET-1
(r = 0.245), ET-1 (r = 0.352) and ET-3 (r = 0.255) levels.
Our regression analysis results confirmed these findings as
well. m-Tyrosine and o-tyrosine are OH• (ROS/RNS)-de-
rived metabolites. Furthermore, we have observed that
treatment of these animals with a superoxide dismutase
mimetic AEOL 10150 abrogated pollutant induced in-
crease in 3-nitrotyrosine and ET-1 levels.(to be published)
These results together imply that air pollution exposure
can trigger oxidative/nitrative stress in lungs that can im-
pact on the endothelinergic system.
Interestingly, disruption of the endothelinergic system
and formation of 3-nitrotyrosine are two well documented
central mechanisms in many disease processes including
atherosclerosis, pulmonary hypertension, asthma, neuro-
logical disorders, cancer and with air pollution and radi-
ation exposure (ozone is known as radiomimetic gas)
[57–67]. It is therefore feasible that air pollutants can
potentially influence such pathologies through these mech-
anistic pathways. This is in line with reports on health-
compromised individuals such as those with existing
cardiovascular disease, asthma, diabetes and cancer as well
as pregnant women, the elderly and children being more
susceptible to air pollution [68–72].
Our findings suggest that exposure to ozone and ambi-
ent particles can lead to systemic nitrative stress, activation
of the endothelinergic system, and elevate endogenous CO
production with a potential for decreasing oxygen delivery.
Our observations argue for biological plausibility and add
to the weight of evidence for adverse health impacts of am-
bient air pollutants thus contributing to the advancement
of risk assessment approaches. The kinetics of interaction
of oxidative and nitrative pathways in our model offer add-
itional insight into the mechanistic bases of epidemiological
findings on the vulnerability of selected population to air
pollution.
Conclusions
Exposures to individual air pollutants result in pollutant-
specific oxidative/nitrative stress changes in lungs and in
circulation. Meanwhile, pollutant mixtures can either cause
additive or suppressive effects or reflect effects due to a
single component depending on which endpoint is being
looked at. In healthy rats, compensatory mechanisms can
be activated. Our results indicate that air pollutant expo-
sures can initiate primary and secondary systemic oxidative
or nitrative stress, changes in hemoglobin variants notably
COHb levels and endothelinergic system that could modu-
late different pathologies, if compensatory mechanisms are
not viable. Future studies using high-content proteomic
analyses to investigate protein expression levels along with
functional modifications can validate and provide further
insight into these air pollutant exposure-specific mechanis-




Dulbecco’s phosphate-buffered saline (PBS, calcium and
magnesium-free), ethylenediaminetetraacetic acid (EDTA),
diethylenetriaminepentaacetic acid (DETPA), phenylmethyl-
sulfonyl fluoride (PMSF), trifluoroacetic acid (TFA), 3,4-
dichloroisocoumarin sodium acetate, trisodium salt of citric
acid, octanesulfonic acid sodium salt (OSA), trizma hydro-
chloride, trizma base, NADPH, sodium hydroxide, nitrate
reductase, sodium nitrite, potassium nitrate, molecular
weight cut-off filters (10 and 30 kDa) and standards of p-
tyrosine, m-tyrosine, o-tyrosine, 3-nitrotyrosine, L-3,4-dihy-
droxyphenylalanine (L-DOPA), 2,4 dinitrophenylhydrazine
(2,4-DNPH), 1,1,3,3-tetra-methoxy-propane, and endothelin
isoform standards (ET-1, ET-2, ET-3) were purchased from
Sigma (St. Louis, MO, USA). Analytical reagent-grade NaCl,
and HCl were from BDH (Toronto, Canada). Reagent-grade
acetone, acetonitrile, and methanol were from commercial
suppliers. Butylated hydroxytoluene (BHT) was from United
Kumarathasan et al. Particle and Fibre Toxicology  (2015) 12:28 Page 11 of 18
States Biochemical Corporation (Cleveland, OH, USA).
Carbonyl-DNPH mix 1 standard was purchased from
Supelco (Bellefonte, PA). Big ET-1 standard was from
Bachem Americas, Inc. (Torrence, CA, USA). Deionized
water (DI water) was from a super-Q plus high purity water
system (Millipore, Bedford, MA, USA). UHP-grade com-
pressed nitrogen was supplied by Matheson Gas products
(Whitby, Canada). Amber glass vials and screw caps with
septa were purchased from Chromatographic specialities,
Inc. (Brockville, ON). 2, 3-diaminonaphthalene was obtained
from Molecular Probes (Eugene, OR). Enzyme immuno-
assay (EIA) kit for 8-isoPGF-2α analysis was purchased from
Cayman chemicals (Ann Arbor, Michigan, USA).
Animals
Specific pathogen-free healthy Fischer-344 male rats (200–
250 g) were obtained from Charles River (St. Constant,
Quebec, Canada). The animals were housed in individual
plexiglass cages on wood-chip bedding under HEPA
filtered air and held to a 12 h dark/light cycle. Food and
water were provided ad libitum. All experimental protocols
were reviewed and approved by the Animal Care Commit-
tee of Health Canada. Animals were randomly allocated to
the different exposure groups (Group size: N = 8/air pollu-
tant exposure group; N = 17/air control group).
Inhalation exposures
Fischer 344 rats were trained in nose-only exposure tubes
over five consecutive days and were exposed for 4 h within
an interaction matrix of ozone (0, 0.4, 0.8 ppm) factored by
EHC-93 particle (0, 5, 50 mg/m3) concentrations by nose-
only inhalation, essentially as described before [15, 24, 27].
Animals were euthanized immediately after exposure (0 h
recovery for the complete 0, 0.4, 0.8 ppm O3 × 0, 5,
50 mg/m3 EHC-93 particle matrix) and 24 h post-
exposure recovery in filtered air (24 h recovery for the 0,
0.8 ppm O3 × 0, 50 mg/m
3 EHC-93 particle matrix). Note
that exposure sessions in the particle-dedicated nose-only
exposure system to different particle concentrations had to
be conducted on different days. In order to minimize day-
of-exposure biases, exposures were staggered and air con-
trol animals were included in a parallel clean-air nose-only
exposure system. For this reason, while treatment groups
(any exposure containing ozone and/or particles) were
blocked to avoid biases and are balanced, the number of
matched animals in the air control groups (N = 17) are
higher than for the treatment groups (N = 8–14), resulting
in an overall unbalanced design. In short, the experimental
design is a three-factor design for the high dose combina-
tions with OZONE (levels 0, 0.8 ppm O3) and EHC-93
particles (levels 0, 50 mg/m3).
Briefly, ozone for the experimental atmosphere was gen-
erated from oxygen in a silent arc generator (Model 200,
Sanders, Uetze, Germany), sampled at the inhalation ports
through a Teflon filter and was monitored by UV
spectrometry (Model 1003-AH, Dasibi Environmental,
Glendale, CA). Ozone concentrations were stabilized
by feedback control and varied ± 5 % of the target
concentration. The EHC-93 particles were dispersed in a
venturi (Powder Disperser Model 3433, TSI St. Paul, MN)
and directed to a flow-past, nose-only exposure inhalation
manifold (CH technologies, Westwood, NJ). One or two
stacks of inhalation manifolds were used for a flow rate of
12–24 L/min (1 L/min per port). The EHC-93 particle
concentrations were tested at the ports by isokinetic sam-
pling on 0.2 μm Teflon filters (Gelman Sciences, Ann
Arbor, MI). Real-time measurements of particle size and
counts were done by isokinetic sampling at the inhalation
ports (Lasair model 301, Particle Measuring Systems,
Boulder, CO). Count median diameter (CMD) and the
mass median aerodynamic diameter (MMAD) were ob-
tained by laser optic counting and cascade impactor ana-
lyses (seven-stage Mercer type, Intox, Albuquerque, NM),
respectively. Resuspended EHC-93 particles contain two
respirable modes at 1.3 μm aerodynamic diameter (DAE)
(mode 1, 20 % of aerosol mass) and 3.6 μm DAE (mode 2,
35 % of aerosol mass), and an additional coarse mode at
15 μm DAE (mode 3), which account for the remaining
45 % of the aerosol mass [24].
Biological samples
Animals were anaesthetized with sodium pentobarbital
(65 mg/kg, i.p.). The trachea was exposed and cannu-
lated, blood was withdrawn from the abdominal aorta
using heparinized syringes and transferred into vacutai-
ner tubes containing the sodium salt of ethylenediamine-
tetraacetic acid (10 mg/mL) and phenyl methyl sulfonyl
fluoride (1.7 mg/mL), mixed gently, and placed on ice.
The diaphragm was then punctured, the lungs were filled
by intra-tracheal instillation of warm saline (37 °C) at
30 mL/kg body weight [73, 74]. Lungs were massaged gen-
tly by rubbing the thoracic cage. Saline was aspirated and
re-injected, twice, and the primary bronchoalveolar lavage
fluid (BALF) was collected in a cold centrifuge tube.
Secondary BALF was obtained with additional volumes of
saline (5 mL/rat), three times, to increase the yield of
lavage cells. The primary and secondary lavage fluids were
centrifuged (300 × g for 10 min at 4 °C) separately to
isolate cells from the supernatants. Primary BALF super-
natants were used to analyse biochemical endpoints.
Secondary BALF supernatants were discarded. Cell pellets
from both primary and secondary BALF supernatants were
combined to recover the total BAL cells.
Analyses of bronchoalveolar lavage
BAL cytology
Lung bronchoalveolar lavage cells were counted using a
Coulter Multisizer II (Coulter Canada, Ville St-Laurent,
Kumarathasan et al. Particle and Fibre Toxicology  (2015) 12:28 Page 12 of 18
Que., Canada), and differential cell counts were obtained
from cytospin preparations using Wright stain and with
use of Ames-Haematic slide stainer following standard
procedures [75].
Lipid oxidation markers in BAL cells
One subset of aliquots of total BAL cells (from the ozone
(0, 0.8 ppm) and particle (0, 50 mg/m3) exposures imme-
diately post recovery) of known cell counts were treated
with stabilizers (25 μL of aqueous 0.1 M DETPA solution
and 25 μL of 0.3 M BHT solution in isopropanol). These
samples were processed for lipid oxidation products (e.g.
aldehydes) analysis, following the procedure reported by
Kumarathasan et al. [16]. Briefly, already stabilized total
BAL cells were lysed by sonication (15 min), and cell sus-
pensions were derivatized with a saturated solution of 2,4-
DNPH in 2 N HCl at room temperature for 1 h. The
DNPH derivatives of the aldehydes were extracted with
toluene, dried over anhydrous sodium sulphate/sila-
nized glass-wool plug, concentrated under N2 and were
analyzed by a previously reported GC-MS method by
Kumarathasan et al. [16] and the analyte peak inten-
sities were recorded.
BALF pH and total protein
pH values of the primary BALF supernatants were initially
recorded using pH strips. Protein concentrations in BALF
supernatants were measured after appropriate dilution in
deionized water by Coomassie brilliant blue dye binding
assay [76]. The remainder of the BALF supernatants were
vortexed with 50 μL of aqueous 0.1 M DETPA solution
and 50 μL of 0.3 M BHT solution in isopropanol to pre-
vent autoxidation of samples. Aliquots of the stabilized
BALF supernatants were analysed for protein carbonyls,
protein oxidation and nitration markers.
BALF protein carbonyls
Aliquots (2 mL) of stabilized BALF supernatant samples
were initially concentrated under a flow of N2 to 250 μL.
These samples were then treated with 10 % ice-cold
TCA, vortexed and centrifuged at 9019 × g for 10 min.
Supernatants were discarded and the precipitates were
treated with 250 μL aliquots of 2,4-DNPH in 2 N HCl,
homogenized, vortexed and allowed to react at room
temperature for 1 h. DNPH-derivatized samples were
then centrifuged at 9019 × g for 10 min, and the precipi-
tate was washed twice with a 1:1 mixture (by volume) of
ethylacetate:ethanol. Washed precipitates were dissolved
in 500 μL of 6 M guanidine HCl solution (pH = 1.8).
These samples were analysed at 280 and 363 nm by UV/
Visible spectrometry (MiltonRoy Spectrometer, LABE-
QUIP LTD, Markham, ON, Canada).
Markers of protein oxidation and nitration
Markers of both reactive oxygen and nitrogen species gen-
eration were analyzed using the HPLC-Coularray method
described by [77]. In brief, 750 μL aliquots of BALF super-
natant samples stabilized with DETPA and BHT were
evaporated to 250 μL under a flow of N2. These samples
were de-proteinized by use of acidified acetone, evapo-
rated to concentrate and were subsequently clarified using
molecular weight cut-off filters (30 kDa). Nitrogen-dried
samples were then reconstituted with 100 μL of acidified
water prior to analysis by a HPLC-Coularray method. Ini-
tial separation of analytes was carried out on a LC-18 re-
versed phase column (25 cm length, 4.6 mm id, 5 μm
particle size; Supelco, Oakville, ON) by isocratic elution
using a citrate-acetate buffer (pH = 4.7) mobile phase con-
taining OSA as the ion-pair reagent. Separated analytes
were measured by coulometric array detection using a set
of eight electrodes at different applied potentials.
Analyses of blood and plasma
Sample preparation
Whole blood samples were initially aliquoted for free ni-
trite analysis and for the analysis of haemoglobin (Hb) var-
iants. Remainder of the whole blood sample was clarified
to obtain plasma following the procedure described by
Kumarathasan et al. [36]. Briefly, blood samples were cen-
trifuged at 1448 × g for 10 min to obtain plasma. Plasma
samples were recovered and vortexed with 50 μL of aque-
ous 0.1 M DETPA solution and 50 μL of 0.3 M BHT solu-
tion in isopropanol to prevent any post-mortem changes
due to autoxidation. Two sets of aliquots (250 μL) of
plasma samples were used for 8-isoPGF2α and for protein
oxidation, nitration marker analyses, while another set of
aliquots was used for analysis of circulating levels of vaso-
regulatory peptides, endothelins.
Hemoglobin variants in blood
Aliquots (50 μL) of stabilized whole blood samples were
diluted with deionized water to a final volume of 1 mL,
were analyzed at 500, 569, 577 and 620 nm [78, 79] for
methemoglobin, carboxyhemoglobin, oxyhemoglobin and
sulfhemoglobin respectively by UV/Visible spectrometry
(MiltonRoy Spectrometer, LABEQUIP LTD, Markham,
ON, Canada) and the absorbance values were recorded.
Carboxyhemoglobin and oxyhemoglobin absorbances were
corrected for interferences.
Plasma 8-isoPGF2α
Aliquots of plasma (250 μL) samples stabilized with
DETPA and BHT were used for the 8-isoPGF2α analysis.
Antibody-based affinity purification of plasma samples was
conducted following the procedure described by Bielecki et
al. [80]. Purified plasma samples were then analyzed by a
competitive enzyme immunoassay (EIA) for 8-isoPGF2α
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using the EIA kit from Cayman Chemicals (Ann Arbor,
Michigan, USA).
Protein oxidation and nitration markers in plasma
Oxidative stress levels in rat plasma were measured by
analysis of protein oxidation and nitration products using
the HPLC-Coularray method described by Kumarathasan
and Vincent [77]. Here, 250 μL aliquots of plasma samples
stabilized with DETPA and BHT were deproteinized using
acidified acetone, evaporated to concentrate, clarified using
molecular weight cut-off filters (30 kDa), dried under N2
flow and were reconstituted with 100 μL of acidified water
prior to analysis by the HPLC-Coularray method as de-
scribed above for the oxidative stress marker levels in
BALF supernatants.
Circulating endothelin isoforms
This procedure was conducted as described by Kumar-
athasan et al. [36]. Briefly, aliquots of plasma samples
(250 μL) were treated with 3,4-dichloroisocoumarin so-
lution in isopropanol to prevent conversion of big ET-1
(BET-1) to ET-1 during sample processing. These sam-
ples were then deproteinized by acidified acetone, evapo-
rated to concentrate and were cleaned up using molecular
weight cut-off filters (30 kDa). Clarified samples were dried
under a N2 flow and were reconstituted in phosphate buff-
ered saline and were analyzed by a reversed phase HPLC-
Fluorescence system. Initial separation of endothelin iso-
forms were carried out on a LC-318 column (25 cm length,
4.6 mm id, 5 μm particle size; Supelco, Oakville, ON) by
gradient elution using water-acetonitrile mobile phase [A-
30 % acetonitrile (aq); B-90 % acetonitrile (aq)] with 0.19 %
of TFA used as the ion-pair reagent. Analytes were mea-
sured by fluorescence detection at excitation and emission
wavelengths of 240 and 380 nm, respectively.
Plasma nitrite
Plasma nitrite analysis was done to determine free nitrite
levels as a supporting endpoint. These analyses were con-
ducted on the immediately post-exposure samples due to
the availability of sample volumes. This analysis method is
based on the thermolysis of all NO-related compounds in
vivo such as nitrosyl metal complexes, nitrite/nitrate, S-
nitroso compounds in plasma to nitrate, followed by en-
zymatic reduction to nitrite that was derivatized using a
fluorescent probe for detection by fluorescence. Nitrite
analysis was conducted following a previously reported
procedure [67]. In essence, plasma samples (50 μL) treated
with DETPA and BHT were thermolyzed at 86 °C, cooled
and filtered via 10 kDa molecular weight cut-off filters.
These samples were treated with nitrate reductase from
Sigma Chemical (St. Louis, MO) at room temperature for
an hour, and were derivatized with 2,3 diaminonaphtha-
lene from Molecular Probes (Eugene, OR). Fluorescence
measurements were made at Ex λ = 360 nm; Em λ =
460 nm on a Cytofluor 2350 multiplate fluorescence de-
tector (Millipore, Bedford, MA).
Relevance of pollutant dose-regimen used in this work to
environmental exposures
To estimate a reference particle deposition in human lungs
in a realistic environmental exposure scenario, we used an
average tidal volume of 875 mL, average breathing fre-
quency of 16 min−1 over the entire day (20.2 m3 air in-
haled/d), oro-nasal breathing, and an alveolar surface area
of 54 m2. For the 0.05–10 μm DAE size range of urban par-
ticulate matter with size cut-off of 10 μm DAE (PM10) con-
sisting of a nucleation mode at 0.05 μm DAE (5 % of mass),
condensation mode at 0.2 μm DAE (25 % of mass) and
coarse mode at 5 μm DAE (70 % of mass) deposition rates
were considered at 0.20 for all three modes. Using these pa-
rameters and assuming a 24 h exposure to an average PM10
concentration of 175 μg/m3, the 95th percentile PM con-
centration in Toronto, would result into a reference total
dose in the pulmonary compartment of humans in the
order of 707 μg (175 μg/m3 × 20.2 m3 × 0.20), translating
into an average surface-specific internal dose of 1.3 ng/cm2
alveolar surface area. Similarly, the peak centriacinar dose
of ozone in human lungs can be considered as 30 × 10−6 μg
O3/cm
2/h per μg ambient O3/m
3 [81]. Thus, for an
0.12 ppm ozone (236 μg O3/m
3) exposure over 12 h (85 ng
O3/cm
2) followed by 0.06 ppm ozone for 12 h (42 ng O3/
cm2), the total daily centriacinar peak surface-specific in-
ternal dose is estimated at 127 ng O3/cm
2 [12].
For rats in our experiments, model assumptions were a
tidal volume of 2.1 mL, breathing frequency of 102 min−1
(51.41 air inhaled /4 h exposure), strict nasal breathing,
and an alveolar surface area of 0.34 m2. We have estimated
deposition rates in the rat lung using the Multiple Path
Particle Deposition software (MPPDep v1.11, RIVM Publi-
cations, Bilthoven, The Netherlands) as at 0.081 for the
1.3 μm DAE mode (20 % of aerosol mass), 0.047 for the
3.6 μm DAE (35 % of aerosol mass) and 0.000 for the
15 μm DAE (45 % of aerosol mass). Therefore, the depos-
ition of EHC-93 particles in the pulmonary compart-
ment of the rats was estimated at 8.4 μg per 5 mg/
m3 exposure concentration (5 μg/L × 51.41 × {[0.20 ×
0.081] + [0.35 × 0.047] + [0.45 × 0.000]}) or 2.5 ng/
cm2 alveolar surface area per 5 mg/m3 exposure con-
centration. The peak centriacinar dose of ozone in rat
lungs can be estimated as 68 × 10−6 μg O3/cm
2/h per
μg ambient O3/m
3 [81]. Thus, exposure of our rats to
0.4 ppm ozone (785 μg O3/m
3) or 0.8 ppm ozone
(1570 μg O3/ m
3) over 4 h should have resulted in total
centriacinar peak doses of 214 ng O3/cm
2 and 427 ng O3/
cm2, respectively.
It is not possible to conduct nose-only inhalation ex-
posures of experimental animals over a 24 h period at a
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dose-rate that reproduces the human exposure experi-
ence. Nose-only exposures with animal restraint should
not exceed 4 h, and thus the dose-rate must be 5–10
times that of the human exposure context to create an
internal experimental dose in animals that approaches
the surface area-specific internal dose in human. The ra-
tios of EHC-93 doses within the respiratory compart-
ment of the rats exposed for 4 h to 5 mg/m3 (2.5 ng/
cm2) and 50 mg/m3 (25 ng/cm2) vs particle dose in hu-
man lungs during plausible 24 h exposure scenarios
(1.3 ng/cm2) were within one order of magnitude (2 and
20-fold respectively). The ratios of ozone centriacinar
peak doses in rats at 0.4 ppm ozone (214 ng O3/cm
2)
and 0.8 ppm ozone (427 ng O3/cm
2) to the estimated in-
ternal dose for human during plausible environmental
exposure scenario (127 ng O3/cm
2) were within an order
of magnitude (1.7 and 3.4-fold respectively). Nose-only
exposures were kept to a minimum duration for ethical
reasons and thus the dose rate in our study was rela-
tively higher as opposed to an environmental exposure
spread over 24 h period. Therefore, from the viewpoint
of toxicological evaluation, the pulmonary deposition or
experimental internal dose in our experimental animals
are directly relevant to human health risk assessment,
particularly if the following uncertainty factors are consid-
ered: interspecies differences in sensitivity to air pollutants
(humans being more responsive than rats), increased sen-
sitivity of the vulnerable population (humans with congest-
ive heart failure or atherosclerosis more responsive than
healthy individuals), and the possible decay of EHC-93
particle potency with collection by comparison to freshly
functionalized particles instantaneously inhaled during
real-time human exposures, albeit to extreme conditions.
If a combined uncertainty of 100-fold is accepted from
those factors, then the internal doses of particles and
ozone created in our animal model become directly com-
parable to a human daily internal pulmonary dose (surface
area- and compartment-specific) under more common ex-
posure conditions, for example 24 h inhalation of 10 ppb
ozone and 50 ug/m3 PM10.
Statistical analyses
Results are expressed as mean ± standard error of the
mean. Most of the endpoints are reported as fold-effect
normalized to controls to remove day-day variation or
animal batch-batch variation as mentioned before. Also,
since multiple endpoints were analysed in this study,
sample sizes varied per analysis (refer to Figure legends)
based on available sample volume or sample loss.
The overall effects of air pollutant exposures were tested
for statistical significance by three-way ANOVA with
OZONE (levels 0, 0.8 ppm O3), EHC-93 (levels 0, 50 mg/
m3 EHC-93) and RECOVERY (levels 0, 24 h post-
exposure) as factors. The detailed dose-interaction model
was then tested for statistical significance by two-way
ANOVA with OZONE (0, 0.4, 0.8 ppm O3) and EHC-93
(0, 5, 50 mg/m3 EHC-93) as factors. For lipid oxidation
product analyses in BAL cells, a two-way ANOVA analysis
was performed with OZONE (levels 0, 0.8 ppm O3) and
EHC-93 (0, 50 mg/m3 EHC-93) as factors. Tukey’s mul-
tiple pair-wise comparison procedure was applied to eluci-
date the patterns of significant effects (α =0.05). Data sets
not meeting the assumptions of normality and equal
variance for ANOVA were subjected to natural log (ln),
square root or rank prior to the analyses. Spearman Rank
Order and Pearson Product Moment correlation analyses
were done to test associations between different endpoints
in different biological compartments. Backward stepwise
regression analysis was also conducted to determine
early markers predictive of late biological events such
as changes in endothelinergic system. For the purpose
of clarity we have reported significant factor interactions in
the Results section. Significant main effects are described in
text only if they were not part of a significant factor inter-
action. Statistical significance reported in the figure leg-
ends and Additional files 4, 5, 6 and 7 refer to the
Tukey’s post-hoc comparison as directed by significant
main effects or factor interactions from the ANOVA tests.
All statistical analyses were conducted using Sigma Stat
software (Version 3.5, Chicago, IL).
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